Profile
Jacqueline Cossmon worked as a Senior Director of Investor Relations at XenoPort, Inc. and as an Investor Relations Contact at Veracyte, Inc. She later worked as a Senior VP of Investor Relations and Communications at Tricida, Inc. from 2018 to 2022.
Former positions of Jacqueline Cossmon
| Companies | Position | End |
|---|---|---|
| TRICIDA, INC. | Investor Relations Contact | 01/01/2022 |
| VERACYTE, INC. | Public Communications Contact | - |
| XENOPORT, INC. | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VERACYTE, INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Jacqueline Cossmon
